Previous Close | 89.19 |
Open | 88.63 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 800 |
Day's Range | 86.02 - 89.02 |
52 Week Range | 83.39 - 180.06 |
Volume | |
Avg. Volume | 785,532 |
Market Cap | 3.699B |
Beta (5Y Monthly) | 0.04 |
PE Ratio (TTM) | 4.30 |
EPS (TTM) | 20.65 |
Earnings Date | Feb 16, 2022 - Feb 21, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 141.50 |
A look at the shareholders of QuidelOrtho Corporation ( NASDAQ:QDEL ) can tell us which group is most powerful...
With me, today to discuss our financial results are Douglas Bryant, QuidelOrtho chairman and CEO; and Joe Busky, QuidelOrtho chief financial officer. This conference call is being simultaneously webcast on the Investor Relations page of our website, and the version of today's presentation can be downloaded there.
SAN DIEGO, August 04, 2022--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading in vitro diagnostics company, today announced financial results for the second quarter ended July 3, 2022.